{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:36:44Z","timestamp":1791419804495,"version":"4.3.3"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.1001\/jamadermatol.2021.5082","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T16:00:57Z","timestamp":1638979257000},"page":"107","source":"Crossref","is-referenced-by-count":31,"title":["Treatment of Severe Nail Lichen Planus With Baricitinib"],"prefix":"10.1001","volume":"158","author":[{"given":"J\u00f6ri","family":"P\u00fcnchera","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Laffitte","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"dlo210018r1","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jaad.2020.02.056","article-title":"Isolated nail lichen planus: an expert consensus on treatment of the classical form.","volume":"83","author":"Iorizzo","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"dlo210018r2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/jamadermatol.2020.4555","article-title":"Tofacitinib as treatment for nail lichen planus associated with alopecia universalis.","volume":"157","author":"Iorizzo","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"511","key":"dlo210018r3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7561","article-title":"IFN-? enhances cell-mediated cytotoxicity against keratinocytes via JAK2\/STAT1 in lichen planus.","volume":"11","author":"Shao","year":"2019","journal-title":"Sci Transl Med"},{"issue":"12","key":"dlo210018r4","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamadermatol.2020.3260","article-title":"Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis: a randomized clinical trial.","volume":"156","author":"Reich","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"dlo210018r5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2021.05.050","article-title":"Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: phase 2 results from a randomized controlled study.","volume":"85","author":"King","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2786977\/jamadermatology_pnchera_2021_lo_210018_1641397674.63582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T16:02:27Z","timestamp":1642608147000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2786977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.5082","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}